Seagen
SGEN
#546
Rank
C$60.24 B
Marketcap
C$319.31
Share price
-0.07%
Change (1 day)
68.18%
Change (1 year)

Seagen (SGEN) - Net assets

Net assets on the balance sheet as of September 2023 : C$3.56 Billion

According to Seagen 's latest financial reports the company has C$3.56 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Seagen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$C$3.80 B-2.6%
2021-12-31$C$3.90 B-12.17%
2020-12-31$C$4.44 B81.49%
2019-12-31$C$2.45 B41.21%
2018-12-31$C$1.73 B103.71%
2017-12-31$C$0.85 B-0.03%
2016-12-31$C$0.85 B-10.44%
2015-12-31$C$0.95 B288.89%
2014-12-31$C$0.24 B-0.15%
2013-12-31$C$0.24 B8.96%
2012-12-31$C$0.22 B1.02%
2011-12-31$C$0.22 B37.88%
2010-12-31$C$0.16 B-25.59%
2009-12-31$C$0.21 B125.82%
2008-12-31$C$96.07 M78.4%
2007-12-31$C$53.85 M-47.58%
2006-12-31$C$0.10 B16.94%
2005-12-31$C$87.85 M-29.56%
2004-12-31$C$0.12 B28.4%
2003-12-31$C$97.13 M31.69%
2002-12-31$C$73.76 M-23.68%
2001-12-31$C$96.65 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ImmunoGen
IMGN
C$0.78 B-77.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$25.41 B 613.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.83 B-76.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C$37.41 M-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$129.95 B 3,550.22%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.56 B 730.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
-C$3.63 Billion-201.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.96 B 629.29%๐Ÿ‡บ๐Ÿ‡ธ USA